Clinical Trials Browser

INDUSTRY × Neoplasms, Plasma Cell × belinostat × Clear all

NCT00431340 2015-07-08

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Bone Marrow Neoplasms, Neoplasms, Plasma Cell